Archives for October 21, 2007

← 2007

Topical Voltaren Gel gets the nod

By  Katrina Megget

Novartis has received US approval for its osteoarthritis pain gel - the first for a topical prescription treatment for the indication.

Viagra could cause hearing loss

By  Mike Nagle

The earth may move and the heavens may shake but drug regulators now think Viagra could also make you go deaf.

Weekly Comment

Pfizer partners in shock after surprise Exubera exit

By  Kirsty Barnes

We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped...

Promega speeds up DNA-protein interaction analysis

By  Dr Matt Wilkinson

Promega has launched a new method of isolating the DNA sequences that bind to proteins that removes the need to generate specific antibodies used in traditional ChIP experiments.

King trims its court following Altace about-turn

By  Anna Lewcock

King Pharmaceuticals last week announced that it would be cutting 20 per cent of its workforce after the US Court of Appeals reversed a previous court ruling and invalidated a patent covering the firm's blood pressure drug, Altace (ramipril).

Keeping sugar-free key to neuron health

By  Mike Nagle

Scientists have discovered how neurons keep themselves sugar-free and healthy, a process that must be upheld to prevent the onset of several neurodegenerative diseases, including a fatal form of epilepsy.